肾细胞癌中细胞外信号调节激酶活性的多区域定量
本研究采用高分辨率纳米免疫分析(NIA)检测38例原发性透明细胞肾细胞癌(RCC)肿瘤多区域共90份离体细针穿刺(FNA)活检样本中ERK磷酸化水平,发现ERK磷酸化存在患者间差异,而个体患者内瘤内异质性有限,提示单次FNA可能代表整个肿瘤的ERK活性。
要点
- NIA可在少量标本中高精度测量蛋白活性。
- ERK磷酸化在患者间存在差异。
- 同一患者肿瘤内ERK磷酸化异质性有限。
核心结论
- ERK磷酸化在RCC患者间存在差异,但同一患者肿瘤内不同区域异质性有限。
- 单次FNA的ERK测量可能代表同一肿瘤不同区域的ERK活性。
研究设计与样本
- 使用高分辨率纳米免疫分析(NIA)定量蛋白活性。
- 对38例原发性透明细胞RCC肿瘤多区域采样,共90份离体FNA活检。
主要发现
- ERK磷酸化在患者间存在差异。
- 同一患者肿瘤内不同区域的ERK磷酸化异质性有限。
临床怎么用
- NIA测量蛋白信号可能提高肾肿块活检的临床实用性。
- 单次FNA可能足以评估ERK活性以辅助精准肿瘤学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To personalize treatment for renal cell carcinoma (RCC), it would be ideal to confirm the activity of druggable protein pathways within individual tumors. We have developed a high-resolution nanoimmunoassay (NIA) to measure protein activity with high precision in scant specimens (eg, fine needle aspirates [FNAs]). Here, we used NIA to determine whether protein activation varied in different regions of RCC tumors. Since most RCC therapies target angiogenesis by inhibiting the vascular endothelial growth factor (VEGF) receptor, we quantified phosphorylation of extracellular signal-regulated kinase (ERK), a downstream effector of the VEGF signaling pathway. In 90 ex vivo FNA biopsies sampled from multiple regions of 38 primary clear cell RCC tumors, ERK phosphorylation differed among patients. In contrast, within individual patients, we found limited intratumoral heterogeneity of ERK phosphorylation. Our results suggest that measuring ERK in a single FNA may be representative of ERK activity in different regions of the same tumor. As diagnostic and therapeutic protein biomarkers are being sought, NIA measurements of protein signaling may increase the clinical utility of renal mass biopsy and allow for the application of precision oncology for patients with localized and advanced RCC. PATIENT SUMMARY: In this report, we applied a new approach to measure the activity of extracellular signal-regulated kinase (ERK), a key cancer signaling protein, in different areas within kidney cancers. We found that ERK activity varied between patients, but that different regions within individual kidney tumors showed similar ERK activity. This suggests that a single biopsy of renal cell carcinoma may be sufficient to measure protein signaling activity to aid in precision oncology approaches.
引用
- Hoerner CR, Massoudi R, Metzner TJ, et al. Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma. Eur Urol Oncol. 2018. PMID: 31412000. doi:10.1016/j.euo.2018.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。